Aqeel Ahmad Fatmi filed an initial statement of beneficial ownership with the SEC on November 9, 2026, disclosing his status as a newly reporting director of Elite Pharmaceuticals Inc /NV/ following a triggering event dated October 28, 2026.

Key Highlights

  • Reporting person: Aqeel Ahmad Fatmi, listed at the address of Elite Pharmaceuticals, Inc., 165 Ludlow Ave., Northvale, New Jersey 07647.
  • Role disclosed: Fatmi is identified in the filing as a Director of Elite Pharmaceuticals Inc /NV/.
  • Triggering event date: The date of event requiring the statement is listed as October 28, 2026.
  • No securities held: Both Table I (non-derivative securities) and Table II (derivative securities) are blank; the filing states explicitly, "No securities are beneficially owned."
  • Filing type: This is an initial filing by one reporting person, not an amendment.

Fatmi Discloses No Beneficial Ownership Upon Joining Elite Pharmaceuticals Board

According to the filing, Aqeel Ahmad Fatmi submitted an initial statement of beneficial ownership (Form 3) in connection with his role as a Director of Elite Pharmaceuticals Inc /NV/, whose ticker symbol is listed in the filing as ELTP. The date of the event requiring the statement is given as October 28, 2026, and the form was signed and filed on November 9, 2026.

The filing reports that Fatmi holds no non-derivative securities and no derivative securities, such as puts, calls, warrants, options, or convertible securities, in Elite Pharmaceuticals Inc /NV/. The form includes the explicit note: "No securities are beneficially owned." Both Table I and Table II, which would otherwise list any directly or indirectly held securities, contain no entries.

The form was filed by one reporting person and is not marked as an amendment. Fatmi's listed address is care of Elite Pharmaceuticals, Inc. at 165 Ludlow Ave., Northvale, New Jersey 07647. The issuer is identified on the cover page as trading under the symbol ELTP, though the filing does not specify an exchange in the registered-securities table beyond listing the ticker.

What Was Disclosed

Aqeel Ahmad Fatmi filed an initial beneficial ownership statement as a Director of Elite Pharmaceuticals Inc /NV/ (ELTP), with an event date of October 28, 2026. The filing discloses that he beneficially owns no securities of the company at the time of filing.